S&P 500   3,005.99 (+0.66%)
DOW   26,834.53 (+0.24%)
QQQ   193.31 (+0.85%)
AAPL   240.27 (+1.63%)
FB   189.42 (+1.92%)
MSFT   138.18 (+0.56%)
GOOGL   1,244.61 (+0.02%)
AMZN   1,782.65 (+1.43%)
CGC   20.35 (+0.69%)
NVDA   195.85 (+2.81%)
MU   45.11 (+3.75%)
BABA   173.84 (+2.78%)
GE   8.80 (-1.90%)
TSLA   253.25 (-1.44%)
AMD   32.01 (+3.36%)
T   38.26 (-0.55%)
F   9.01 (-3.01%)
NFLX   277.61 (+0.84%)
BAC   31.12 (+2.50%)
GILD   65.17 (+0.40%)
S&P 500   3,005.99 (+0.66%)
DOW   26,834.53 (+0.24%)
QQQ   193.31 (+0.85%)
AAPL   240.27 (+1.63%)
FB   189.42 (+1.92%)
MSFT   138.18 (+0.56%)
GOOGL   1,244.61 (+0.02%)
AMZN   1,782.65 (+1.43%)
CGC   20.35 (+0.69%)
NVDA   195.85 (+2.81%)
MU   45.11 (+3.75%)
BABA   173.84 (+2.78%)
GE   8.80 (-1.90%)
TSLA   253.25 (-1.44%)
AMD   32.01 (+3.36%)
T   38.26 (-0.55%)
F   9.01 (-3.01%)
NFLX   277.61 (+0.84%)
BAC   31.12 (+2.50%)
GILD   65.17 (+0.40%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 ExelixisSyneos HealthCharles River Laboratories Intl.PRA Health SciencesBTG
SymbolNASDAQ:EXELNASDAQ:SYNHNYSE:CRLNASDAQ:PRAHN/A
Price Information
Current Price$16.75$54.47$128.27$97.04N/A
52 Week RangeBuyBuyBuyHoldHold
Analyst Ratings
Consensus RecommendationBuyBuyBuyHoldHold
Consensus Price Target$28.29$60.14$150.33$115.86N/A
% Upside from Price Target68.92% upside10.41% upside17.20% upside19.39% upsideN/A
Trade Information
Market Cap$4.97 billion$5.69 billion$6.64 billion$6.49 billion$3.88 billion
Beta1.811.511.091.120.26
Average Volume2,610,482391,117345,130387,042777
Sales & Book Value
Annual Revenue$853.83 million$4.39 billion$2.27 billion$2.87 billionN/A
Price / Sales5.941.282.762.23N/A
Cashflow$1.50 per share$5.23 per share$8.94 per share$5.77 per shareN/A
Price / Cash11.2010.4214.3516.81N/A
Book Value$4.31 per share$27.67 per share$27.37 per share$16.18 per shareN/A
Price / Book3.891.974.696.00N/A
Profitability
Net Income$690.07 million$24.28 million$226.37 million$153.90 millionN/A
EPS$1.43$2.62$6.03$3.93N/A
Trailing P/E Ratio11.7120.7921.2724.690.00
Forward P/E Ratio15.8017.1317.3118.17N/A
P/E GrowthN/A$1.93$1.74$1.33N/A
Net Margins70.52%0.36%8.94%5.39%N/A
Return on Equity (ROE)31.31%9.82%22.01%26.64%N/A
Return on Assets (ROA)28.23%3.81%7.38%8.63%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.02%0.99%1.47%1.11%N/A
Current Ratio8.64%0.89%1.59%0.99%N/A
Quick Ratio8.53%0.89%1.38%0.99%N/A
Ownership Information
Institutional Ownership Percentage77.41%N/A94.25%98.94%N/A
Insider Ownership Percentage4.50%0.44%1.80%0.95%N/A
Miscellaneous
Employees48424,00014,70016,4001,631
Shares Outstanding302.91 million103.49 million48.81 million65.88 million386.49 million
Next Earnings Date10/30/2019 (Confirmed)10/31/2019 (Confirmed)11/6/2019 (Estimated)10/30/2019 (Confirmed)N/A
OptionableOptionableOptionableOptionableOptionableNot Optionable
 ExelixisSyneos HealthCharles River Laboratories Intl.PRA Health SciencesBTG

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel